The abstract is read at the publisher; the summary is JClub's.
CMA of 849 pregnancy-loss products of conception found chromosomal or genomic abnormalities in 62.19% (528) of samples, dominated by trisomies, monosomies, and polyploidies.
- Why it matters: Genetic counseling and recurrence-risk estimates depend on knowing which chromosomal abnormalities are present in pregnancy loss, and how detection varies with maternal age.
- What they did: From January 2016 to December 2025, 849 POC samples were analyzed with the Affymetrix CytoScan 750K array, with CNV pathogenicity classified using ACMG/ClinGen criteria and age associations tested with chi-square, trend, and logistic regression.
- The result: Pathogenic abnormality detection rose with maternal age, increasing from 48.99% (<30 years) to 73.81% (≥40 years), with odds ratio 2.93 (95% CI 1.76–4.89), implying higher genetic contribution in older patients.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.